Stockscreener 앱 받기
2.3691
0.84%
-0.0009
전일 마감가:
$2.37
열려 있는:
$2.36
하루 거래량:
52,430
Relative Volume:
0.97
시가총액:
$69.42M
수익:
$3.04M
순이익/손실:
$-33.97M
주가수익비율:
-1.7167
EPS:
-1.38
순현금흐름:
$-52.47M
1주 성능:
-13.60%
1개월 성능:
-15.77%
6개월 성능:
-29.11%
1년 성능:
-14.23%
1일 변동 폭
$2.31
$2.42
1주일 범위:
$2.29
$2.7586
52주 변동 폭
$1.82
$8.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
명칭
Rani Therapeutics Holdings Inc
전화
(408) 457-3700
주소
2051 RINGWOOD AVENUE, SAN JOSE
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-07-27 | 개시 | H.C. Wainwright | Buy |
| 2022-06-13 | 개시 | Wedbush | Outperform |
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
Rani Therapeutics appoints Marcum as new auditor - Investing.com India
Rani Therapeutics appoints Marcum as new auditor By Investing.com - Investing.com Canada
Rani Therapeutics appoints Marcum as new auditor By Investing.com - Investing.com UK
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) market cap dropped US$17m last week; Retail investors bore the brunt - Simply Wall St
Rani Therapeutics to Participate in September Investor Conferences - ForexTV.com
Rani Therapeutics to Participate in September Investor Conferences - GlobeNewswire
Rani Therapeutics to Participate in September Investor Conferences - StockTitan
Vanguard Group Inc. Has $2.13 Million Holdings in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week - Yahoo Finance
RANIRani Therapeutics Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Rani Therapeutics (NASDAQ:RANI) PT Lowered to $9.00 - Defense World
Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Price Target at $12.38 - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of “Buy” from Analysts - Defense World
Rani Therapeutics (NASDAQ:RANI) Given New $9.00 Price Target at HC Wainwright - MarketBeat
Rani Therapeutics stock target cut, rating held on Q2 results By Investing.com - Investing.com Canada
Rani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright - TipRanks
FY2024 EPS Estimates for Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Lowered by Analyst - MarketBeat
Brokers Set Expectations for Rani Therapeutics Holdings, Inc.’s FY2024 Earnings (NASDAQ:RANI) - Defense World
FY2024 EPS Estimates for Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Reduced by Analyst - Defense World
How To Buy Rani Therapeutics Holdings, Inc. Stock Online in August 2024 - Traders Union
Rani Therapeutics (NASDAQ:RANI) Announces Quarterly Earnings Results - MarketBeat
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - GlobeNewswire
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - StockTitan
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - Yahoo Finance
Rani Therapeutics (NASDAQ:RANI) Coverage Initiated at Oppenheimer - Defense World
Rani Therapeutics (NASDAQ:RANI) Receives New Coverage from Analysts at Oppenheimer - MarketBeat
Rani Therapeutics initiated with an Outperform at Oppenheimer - TipRanks
Rani Therapeutics to Participate in August Investor Conferences - GlobeNewswire
Rani Therapeutics to Participate in August Investor Conferences - StockTitan
Rani Therapeutics to Participate in August Investor Conferences - Yahoo Finance
Rani Therapeutics secures $10 million in stock sale - Investing.com India
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of “Buy” from Analysts - Defense World
Form 424B5 Rani Therapeutics Holdin - StreetInsider.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.29 Consensus Target Price from Analysts - MarketBeat
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - ForexTV.com
Rani Therapeutics secures $10 million in stock sale By Investing.com - Investing.com UK
Rani Therapeutics prices securities offering to raise $10 million - Seeking Alpha
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - GlobeNewswire
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - StockTitan
Does Rani Therapeutics Holdings (NASDAQ:RANI) Have A Healthy Balance Sheet? - Simply Wall St
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update - WICZ
Rani Therapeutics (NASDAQ:RANI) versus Cingulate (NASDAQ:CING) Critical Contrast - Defense World
Quantum Corp amends credit agreements, issues stock warrants - Investing.com
HF direct investments pool sells shares of Westrock Coffee Co for $188k By Investing.com - Investing.com India
Rani Therapeutics opts out of equity financing amid market review - Investing.com
HF direct investments pool sells shares of Westrock Coffee Co for $188k By Investing.com - Investing.com UK
Rani Therapeutics Reevaluates Equity Financing Strategy - TipRanks
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
RANI: GLP-2 Deal Announced - Research Tree
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Rani Therapeutics Holdings Inc (RANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rani Therapeutics Holdings Inc 주식 (RANI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Nov 24 '23 |
Buy |
2.01 |
5,265,165 |
10,582,982 |
12,131,554 |
| Imran Talat | Chief Executive Officer |
Dec 06 '23 |
Buy |
2.27 |
10,000 |
22,700 |
484,455 |
| Imran Talat | Chief Executive Officer |
Dec 04 '23 |
Buy |
2.57 |
5,000 |
12,850 |
474,455 |
| Imran Talat | Chief Executive Officer |
Nov 29 '23 |
Buy |
2.05 |
20,000 |
41,000 |
469,455 |
| BUTEL JEAN LUC | Director |
Nov 17 '23 |
Buy |
2.03 |
50,500 |
102,495 |
50,500 |
| Nanavaty Maulik | Director |
Nov 16 '23 |
Buy |
1.98 |
500 |
990 |
500 |
| Imran Talat | Chief Executive Officer |
Nov 07 '23 |
Buy |
2.00 |
5,000 |
9,975 |
449,455 |
1.26%
1.94%
자본화:
|
볼륨(24시간):